Former President Biden Completes Radiation Treatment For Aggressive Prostate Cancer

Former US President Joe Biden has completed radiation therapy for an aggressive form of prostate cancer with a Gleason score of 9. The 82-year-old received treatment at Penn Medicine in Philadelphia following his diagnosis earlier this year which revealed the cancer had spread to his bones. This health challenge comes months after Biden withdrew from the 2024 presidential race.

Biden Finishes Round Of Radiation Therapy For Prostate Cancer Treatment

Former US President Joe Biden has completed his scheduled radiation therapy treatment for an aggressive form of prostate cancer, according to a spokesperson statement released Monday.

The treatment was administered at Penn Medicine Radiation Oncology in Philadelphia, as confirmed by Biden's aide Kelly Scully.

The 82-year-old former Democratic president, who left office in January, had stepped away from his reelection campaign six months prior following a widely criticized debate performance against Republican Donald Trump. His withdrawal came amid growing public concerns regarding his age, health status, and cognitive capabilities. Trump subsequently defeated Vice President Kamala Harris, who had replaced Biden as the Democratic nominee.

Biden's postpresidential office revealed in May that he had received a prostate cancer diagnosis, with tests indicating the disease had metastasized to his bones. The diagnosis came after Biden had reported experiencing urinary symptoms.

Medical professionals classify prostate cancers according to aggressiveness using the Gleason scoring system, which ranges from 6 to 10. Scores of 8, 9, and 10 indicate more aggressive forms of the disease. Biden's cancer received a Gleason score of 9, placing it among the most aggressive classifications.

In a separate health matter last month, the former president underwent a procedure to remove cancerous skin lesions from his forehead.

Source: https://www.ndtv.com/world-news/joe-biden-finishes-a-round-of-radiation-therapy-for-prostate-cancer-treatment-9489595